Skip to main content
logo
Elicera Therapeutics AB (publ) (STO:ELIC)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.810
+0.150 (5.64%)
Sep 2, 2026, 5:29 PM CET

Elicera Therapeutics AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
7.7910.867.1311.231.280
Revenue Growth
29.45%52.28%-36.52%777.23%217987.39%-
Gross Profit
7.7910.867.1311.231.280
Operating Income
-18.41-17.94-16.88-17.1-19.36-13.12
Net Income
-17.98-17.41-16.11-16.4-19.44-13.12
Earnings Per Share
--0.38-0.51-0.83-0.98-0.82
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
58.1324.8526.429.3843.8252.39
Net Cash Growth
46.56%-5.88%-10.15%-32.95%-16.36%353.04%
Net Cash Per Share
-0.540.841.492.213.27
Cash & Investments
58.1324.8526.429.3843.8252.39

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-25.75-21.55-23.46-14.92-8.57-14.29
Free Cash Flow
-25.75-21.55-23.46-14.92-8.57-14.29
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-236.19%-165.31%-236.86%-152.24%-1512.51%-2234986.20%
Pretax Margin
-230.77%-160.35%-226.01%-146.02%-1518.44%-2235169.17%
Profit Margin
-230.77%-160.35%-226.01%-146.02%-1518.44%-2235169.17%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
22.7823.348.228.0354.32169174.86